106 related articles for article (PubMed ID: 12358259)
1. External validation of a prognostic model for predicting survival of cirrhotic patients with refractory ascites.
Guardiola J; Baliellas C; Xiol X; Fernandez Esparrach G; Ginès P; Ventura P; Vazquez S
Am J Gastroenterol; 2002 Sep; 97(9):2374-8. PubMed ID: 12358259
[TBL] [Abstract][Full Text] [Related]
2. Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt.
Guardiola J; Xiol X; Escribá JM; Castellví JM; Castellote J; Baliellas C; Rafecas A; Casais LA
Am J Gastroenterol; 1995 Dec; 90(12):2097-102. PubMed ID: 8540495
[TBL] [Abstract][Full Text] [Related]
3. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites.
Moreau R; Delègue P; Pessione F; Hillaire S; Durand F; Lebrec D; Valla DC
Liver Int; 2004 Oct; 24(5):457-64. PubMed ID: 15482343
[TBL] [Abstract][Full Text] [Related]
5. Predictive models of short- and long-term survival in patients with nonbiliary cirrhosis.
Longheval G; Vereerstraeten P; Thiry P; Delhaye M; Le Moine O; Devière J; Bourgeois N; Adler M
Liver Transpl; 2003 Mar; 9(3):260-7. PubMed ID: 12619023
[TBL] [Abstract][Full Text] [Related]
6. Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS.
Bureau C; Métivier S; D'Amico M; Péron JM; Otal P; Pagan JC; Chabbert V; Chagneau-Derrode C; Procopet B; Rousseau H; Bosch J; Vinel JP
J Hepatol; 2011 May; 54(5):901-7. PubMed ID: 21145798
[TBL] [Abstract][Full Text] [Related]
7. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in patients with refractory ascites treated by transjugular intrahepatic porto-systemic shunt: From the liver to the kidney.
Hamel B; Guillaud O; Roman S; Vallin M; Pilleul F; Valette PJ; Henry L; Guibal A; Mion F; Dumortier J
Dig Liver Dis; 2014 Nov; 46(11):1001-7. PubMed ID: 25096966
[TBL] [Abstract][Full Text] [Related]
9. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.
Schepke M; Roth F; Fimmers R; Brensing KA; Sudhop T; Schild HH; Sauerbruch T
Am J Gastroenterol; 2003 May; 98(5):1167-74. PubMed ID: 12809844
[TBL] [Abstract][Full Text] [Related]
10. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
[TBL] [Abstract][Full Text] [Related]
11. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
Uriz J; Cárdenas A; Arroyo V
Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):927-43. PubMed ID: 11139347
[TBL] [Abstract][Full Text] [Related]
13. Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients.
Salerno F; Borroni G; Moser P; Badalamenti S; Cassarà L; Maggi A; Fusini M; Cesana B
Am J Gastroenterol; 1993 Apr; 88(4):514-9. PubMed ID: 8470631
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.
Salerno F; Merli M; Riggio O; Cazzaniga M; Valeriano V; Pozzi M; Nicolini A; Salvatori F
Hepatology; 2004 Sep; 40(3):629-35. PubMed ID: 15349901
[TBL] [Abstract][Full Text] [Related]
15. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
16. Clinical practice guidelines for the management of cirrhotic patients with ascites. Committee on Ascites of the Italian Association for the Study of the Liver.
Salerno F; Angeli P; Bernardi M; Laffi G; Riggio O; Salvagnini M
Ital J Gastroenterol Hepatol; 1999 Oct; 31(7):626-34. PubMed ID: 10604107
[TBL] [Abstract][Full Text] [Related]
17. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
18. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients.
Alvares-da-Silva MR; Reverbel da Silveira T
Nutrition; 2005 Feb; 21(2):113-7. PubMed ID: 15723736
[TBL] [Abstract][Full Text] [Related]
19. Natural history of patients hospitalized for management of cirrhotic ascites.
Planas R; Montoliu S; Ballesté B; Rivera M; Miquel M; Masnou H; Galeras JA; Giménez MD; Santos J; Cirera I; Morillas RM; Coll S; Solà R
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1385-94. PubMed ID: 17081806
[TBL] [Abstract][Full Text] [Related]
20. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
